{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:38:33Z","timestamp":1762004313900},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1038\/ijir.2011.6","type":"journal-article","created":{"date-parts":[[2011,3,24]],"date-time":"2011-03-24T08:54:22Z","timestamp":1300956862000},"page":"70-75","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Should assessment of penetrative sexual activity be used as the treatment arbiter in the management of Peyronie's disease?"],"prefix":"10.1038","volume":"23","author":[{"given":"I","family":"Dukic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Thakare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S R","family":"Payne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,24]]},"reference":[{"key":"BFijir20116_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1046\/j.1464-4096.2001.02436.x","volume":"88","author":"U Schwarzer","year":"2001","unstructured":"Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U . The prevalence of Peyronie's disease: results of a large survey. BJU Int 2001; 88: 727\u2013730.","journal-title":"BJU Int"},{"key":"BFijir20116_CR2","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.eururo.2005.10.026","volume":"49","author":"AI El-Sakka","year":"2006","unstructured":"El-Sakka AI . Prevalence of Peyronie's disease among patients with erectile dysfunction. Eur Urol 2006; 49: 564\u2013569.","journal-title":"Eur Urol"},{"key":"BFijir20116_CR3","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1097\/01.ju.0000170231.51306.32","volume":"174","author":"AI El-Sakka","year":"2005","unstructured":"El-Sakka AI, Tayeb KA . Peyronie's disease in diabetic patients being screened for erectile dysfunction. J Urol 2005; 174: 1026\u20131030.","journal-title":"J Urol"},{"issue":"Part 1","key":"BFijir20116_CR4","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1097\/01.ju.0000127744.18878.f1","volume":"171","author":"JP Mulhall","year":"2004","unstructured":"Mulhall JP, Creech SD, Boorjian SA, Ghaly S, Kim ED, Moty A et al. Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening. J Urol 2004; 171 (Part 1): 2350\u20132353.","journal-title":"J Urol"},{"key":"BFijir20116_CR5","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.eururo.2006.02.059","volume":"49","author":"EW Hauck","year":"2006","unstructured":"Hauck EW, Diemer T, Schmelz HU, Weidner W . A critical analysis of nonsurgical treatment of Peyronie's disease. Eur Urol 2006; 49: 987\u2013997.","journal-title":"Eur Urol"},{"key":"BFijir20116_CR6","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/S0022-5347(06)00270-9","volume":"175","author":"JP Mulhall","year":"2006","unstructured":"Mulhall JP, Schiff J, Guhring P . An analysis of the natural history of Peyronie's disease. J Urol 2006; 175: 2115\u20132118.","journal-title":"J Urol"},{"key":"BFijir20116_CR7","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S0022-5347(05)64578-8","volume":"168","author":"A Kadioglu","year":"2002","unstructured":"Kadioglu A, Tefekli A, Erol B, Oktar T, Tunc M, Tellaloglu S . A retrospective review of 307 men with Peyronie's disease. J Urol 2002; 168: 1075\u20131079.","journal-title":"J Urol"},{"issue":"Suppl 5","key":"BFijir20116_CR8","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.1038\/sj.ijir.3901083","volume":"15","author":"LA Levine","year":"2003","unstructured":"Levine LA, Greenfield JM . Establishing a standardized evaluation of the man with Peyronie's disease. Int J Impot Res 2003; 15 (Suppl 5): S103\u2013S112.","journal-title":"Int J Impot Res"},{"key":"BFijir20116_CR9","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/S0022-5347(17)39746-X","volume":"144","author":"MK Gelbard","year":"1990","unstructured":"Gelbard MK, Dorey F, James K . The natural history of Peyronie's disease. J Urol 1990; 144: 1376\u20131379.","journal-title":"J Urol"},{"key":"BFijir20116_CR10","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.eururo.2004.12.022","volume":"47","author":"W Weidner","year":"2005","unstructured":"Weidner W, Hauck EW, Schnitker J . Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease: a prospective, placebo-controlled, randomized study. Eur Urol 2005; 47: 530\u2013535, discussion 535\u2013536.","journal-title":"Eur Urol"},{"key":"BFijir20116_CR11","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/sj.ijir.3900869","volume":"14","author":"LA Mynderse","year":"2002","unstructured":"Mynderse LA, Monga M . Oral therapy for Peyronie's disease. Int J Impot Res 2002; 14: 340\u2013344.","journal-title":"Int J Impot Res"},{"key":"BFijir20116_CR12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/sj.ijir.3901185","volume":"16","author":"MR Safarinejad","year":"2004","unstructured":"Safarinejad MR . Therapeutic effects of colchicine in the management of Peyronie's disease: a randomized double-blind, placebo-controlled study. Int J Impot Res 2004; 16: 238\u2013243.","journal-title":"Int J Impot Res"},{"key":"BFijir20116_CR13","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1016\/S0022-5347(05)68087-1","volume":"162","author":"C Teloken","year":"1999","unstructured":"Teloken C, Rhoden EL, Grazziotin TM, Ros CT, Sogari PR, Souto CA . Tamoxifen versus placebo in the treatment of Peyronie's disease. J Urol 1999; 162: 2003\u20132005.","journal-title":"J Urol"},{"key":"BFijir20116_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.juro.2006.04.009","volume":"176","author":"RB Meacham","year":"2006","unstructured":"Meacham RB . Nonsurgical management of Peyronie's disease\u2014are we making any progress? J Urol 2006; 176: 12\u201313.","journal-title":"J Urol"},{"key":"BFijir20116_CR15","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S0022-5347(06)00517-9","volume":"176","author":"WJG Hellstrom","year":"2006","unstructured":"Hellstrom WJG, Kendirci M, Matern R, Cockerham Y, Myers L, Sikka SC et al. Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease. J Urol 2006; 176: 394\u2013398.","journal-title":"J Urol"},{"key":"BFijir20116_CR16","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1016\/S0022-5347(05)65085-9","volume":"167","author":"SS Gholami","year":"2002","unstructured":"Gholami SS, Lue TF . Correction of penile curvature using the 16-dot plication technique: a review of 132 patients. J Urol 2002; 167: 2066\u20132069.","journal-title":"J Urol"},{"key":"BFijir20116_CR17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1159\/000019624","volume":"33","author":"N Thiounn","year":"1998","unstructured":"Thiounn N, Missirliu A, Zerbib M, Larrouy M, Dje K, Flam T et al. Corporeal plication for surgical correction of penile curvature. Experience with 60 patients. Eur Urol 1998; 33: 401\u2013404.","journal-title":"Eur Urol"},{"key":"BFijir20116_CR18","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1046\/j.1464-410X.1996.97621.x","volume":"77","author":"UA Geertsen","year":"1996","unstructured":"Geertsen UA, Brok KE, Andersen B, Nielsen HV . Peyronie curvature treated by plication of the penile fasciae. Br J Urol 1996; 77: 733\u2013735.","journal-title":"Br J Urol"},{"key":"BFijir20116_CR19","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.eururo.2007.04.045","volume":"53","author":"A Kadioglu","year":"2008","unstructured":"Kadioglu A, Sanli O, Akman T, Cakan M, Erol B, Mamadov F . Surgical treatment of Peyronie's disease: a single center experience with 145 patients. Eur Urol 2008; 53: 432\u2013439.","journal-title":"Eur Urol"},{"key":"BFijir20116_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.eururo.2006.04.030","volume":"50","author":"A Kadioglu","year":"2006","unstructured":"Kadioglu A, Akman T, Sanli O, Gurkan L, Cakan M, Celtik M . Surgical treatment of Peyronie's disease: a critical analysis. Eur Urol 2006; 50: 235\u2013248.","journal-title":"Eur Urol"},{"key":"BFijir20116_CR21","first-page":"325","volume":"157","author":"W Weidner","year":"1997","unstructured":"Weidner W, Schroeder-Printzen I, Weiske W, Vosshenrich R . Sexual dysfunction in Peyronie's disease: an analysis of 222 patients without previous local plaque therapy. JUrol 1997; 157: 325\u2013328.","journal-title":"JUrol"},{"key":"BFijir20116_CR22","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/S0022-5347(01)68184-9","volume":"158","author":"LA Levine","year":"1997","unstructured":"Levine LA, Lenting EL . A surgical algorithm for the treatment of Peyronie's disease. J Urol 1997; 158: 2149\u20132152.","journal-title":"J Urol"},{"key":"BFijir20116_CR23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/sj.ijir.3900472","volume":"11","author":"RC Rosen","year":"1999","unstructured":"Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pe\u00f1a BM . Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319\u2013326.","journal-title":"Int J Impot Res"},{"key":"BFijir20116_CR24","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1159\/000049850","volume":"40","author":"JM Mart\u00ednez-Jabaloyas","year":"2001","unstructured":"Mart\u00ednez-Jabaloyas JM, Gil-Salom M, Villam\u00f3n-Fort R, Pastor-Hern\u00e1ndez F, Mart\u00ednez-Garc\u00eda R, Garc\u00eda-Sisam\u00f3n F . Prognostic factors for response to sildenafil in patients with erectile dysfunction. Eur Urol 2001; 40: 641\u2013646, discussion 647.","journal-title":"Eur Urol"},{"key":"BFijir20116_CR25","first-page":"47","volume":"8","author":"M Boolell","year":"1996","unstructured":"Boolell M, Allen MJ, Ballard SA, Gepi-Attee S, Muirhead GJ, Naylor AM et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996; 8: 47\u201352.","journal-title":"Int J Impot Res"},{"key":"BFijir20116_CR26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nrurol.2010.24","volume":"7","author":"NF Gonzalez-Cadavid","year":"2010","unstructured":"Gonzalez-Cadavid NF, Rajfer J . Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy. Nat Rev Urol 2010; 7: 215\u2013221.","journal-title":"Nat Rev Urol"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ijir20116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ijir20116","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ijir20116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T15:39:40Z","timestamp":1648654780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ijir20116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["BFijir20116"],"URL":"https:\/\/doi.org\/10.1038\/ijir.2011.6","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"1 November 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}